Aakaar Medical Technologies IPO Subscribed 0.37x on Day 1

Aakaar Medical Technologies IPO subscribed over 0.37x on its First day of subscription, wherein QIB subscribed 0.33x, NII subscribed 0.59x, and RII subscribed 0.30x.

Aakaar Medical Technologies’ IPO subscription started on Friday, June 20, 2025, and will close on June 24, 2025, as per the schedule. The price band is set at ₹68 to ₹72 per share with a face value of ₹10. 

Aakaar Medical Technologies IPO Subscription Status

Aakaar Medical Technologies IPO subscribed over 0.37x on its First day till 05.00 PM on 20th June 2025. 

  • Aakaar Medical Technologies IPO subscription QIB investors portion is 0.33x times, while NII subscribed 0.59x times, and RII investors subscribed 0.30x times.  
  • The company has received bids for 9,31,200 shares against 24,96,000 shares on offer on the First day. 
  • Aakaar Medical Technologies’ IPO subscribed over 0.37x times on day 1. 

About Aakaar Medical Technologies IPO

Incorporated in 2013, Aakaar Medical Technologies Ltd. is one of the leading medical companies that focuses on providing a wide range of aesthetic and specialized cosmetic products and devices. The company is known to offer specialty products for Dermatologists, Plastic Surgeons, Aesthetic Physicians, and Cosmetologists. The company’s portfolio comprises both its own products and internationally produced devices obtained from various countries such as South Korea, Spain, Italy, and Austria, serving its products and devices to dermatologists, plastic surgeons, and aesthetic physicians, who sell to customers or use them in various treatments. The company’s product range consists of Homecare and professional skin care, Injectable and contouring, Homecare for skin, Professional Hair Care, Professional Skincare products, Hair Growth Serum & Tablets, Medifacial Kit, Device for urinary incontinence, Tattoo removal, pigmentation, and skin rejuvenation devices, Laser Hair Reduction devices and Hair Transplant Device. As of now, the company consists of a team of 90 trained engineers and salespeople. Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu are some of the major states where the company sells its products.

Aakaar Medical Technologies IPO Company Financial Report

The company reported revenue of ₹61.76 crores in 2025 against ₹46.27 crores in 2024. The company reported a profit of ₹6.04 crores in 2025 against a profit of ₹2.87 crores in 2024.

Aakaar Medical Technologies IPO GMP

Aakaar Medical Technologies’ IPO GMP was ₹0 as of Friday, 20th June. That indicates the IPO is trading at ₹138 with a ₹0 premium in the grey market against the issue price of ₹138.

Share the Post:
Facebook
Twitter
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *